Generalized Anxiety Disorder - Pipeline Insight, 2021

SKU ID :DEL-19044458 | Published Date: 01-Sep-2021 | No. of pages: 60
Introduction Executive Summary Generalized Anxiety Disorder: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Late Stage Products (Phase III) • Comparative Analysis Cannabidiol: Tilray • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis Cariprazine: Allergan • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Preclinical stage products • Comparative Analysis PSY-05: PSY Therapeutics • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Generalized Anxiety Disorder Key Companies Generalized Anxiety Disorder Key Products Generalized Anxiety Disorder- Unmet Needs Generalized Anxiety Disorder- Market Drivers and Barriers Generalized Anxiety Disorder- Future Perspectives and Conclusion Generalized Anxiety Disorder Analyst Views Generalized Anxiety Disorder Key Companies Appendix
Table 1 Total Products for Generalized Anxiety Disorder Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products
• ChemRar Research and Development Institute, LLC • Tilray • PSY Therapeutics • VistaGen Therapeutics • SAGE Therapeutics • Bionomics • Pear Therapeutics • Lundbeck • OWP Pharmaceuticals • Fabre-Kramer Pharmaceuticals
  • PRICE
  • $1500
    $4500

Our Clients